NCT00644618View on ClinicalTrials.gov

Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions
Locally Advanced Pancreatic Cancer
Interventions
DRUG

gemcitabine

a 30-minute intravenous infusions of gemcitabine 1,000 mg/m2 weekly×7, followed by a 1-week pause, and then weekly×3

OTHER

125I brachytherapy PLUS gemcitabine

125I brachytherapy PLUS a 30-minute intravenous infusions of gemcitabine 1,000 mg/m2 weekly×7, followed by a 1-week pause, and then weekly×3

All Listed Sponsors
lead

Huazhong University of Science and Technology

OTHER

NCT00644618 - Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy | Biotech Hunter | Biotech Hunter